Patent: 9,186,392
✉ Email this page to a colleague
Summary for Patent: 9,186,392
Title: | Combination therapy |
Abstract: | The present invention relates to methods for treating and/or preventing metabolic diseases comprising the combined administration of a GLP-1 receptor agonist and a DPP-4 inhibitor. |
Inventor(s): | Klein; Thomas (Radolfzell, DE), Grempler; Rolf (Birkenhard/Warthausen, DE), Mark; Michael (Biberach an der Riss, DE) |
Assignee: | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) |
Application Number: | 13/695,492 |
Patent Claims: | see list of patent claims |
Details for Patent 9,186,392
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Amryt Pharmaceuticals Dac | MYALEPT | metreleptin | For Injection | 125390 | 02/24/2014 | ⤷ Try a Trial | 2030-05-05 |
Glaxosmithkline Llc | TANZEUM | albiglutide | For Injection | 125431 | 04/15/2014 | ⤷ Try a Trial | 2030-05-05 |
Eli Lilly And Company | TRULICITY | dulaglutide | Injection | 125469 | 09/18/2014 | ⤷ Try a Trial | 2030-05-05 |
Eli Lilly And Company | TRULICITY | dulaglutide | Injection | 125469 | 09/04/2020 | ⤷ Try a Trial | 2030-05-05 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |